Suppr超能文献

抗菌药物管理计划对多重耐药革兰阴性菌抗菌药物使用及检出率的影响

[Impact of antimicrobial stewardship program on antimicrobial usage and detection rate of multidrug-resistant gram-negative bacteria].

作者信息

Xu Y L, Hu L M, Xie Z Z, Dong Y W, Dong L

机构信息

Department of Respiratory Diseases, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, China (Xu Yulan is working on the Department of Pediatrics, Zhoushan Maternal and Child Health Hospital, Zhoushan 316000, China).

Department of Nosocomial Infection Management and Disease Control, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, China.

出版信息

Zhonghua Er Ke Za Zhi. 2019 Jul 2;57(7):553-558. doi: 10.3760/cma.j.issn.0578-1310.2019.07.012.

Abstract

Analyze the changes of indicator of antimicrobial usage and detection rate of multidrug-resistant gram-negative bacteria (MDR-GNB), in order to evaluate the impact of antimicrobial stewardship program (ASP). The antimicrobial stewardship program was implemented since December 2011 at the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University. Intensified effort was made from 2014 to 2017. We divided the program into four stages, one before ASP (2010-2011) and three after ASP (2012-2013 as the first, 2014-2015 as the second and 2016-2017 as the third post-ASP stages). The usage rates in outpatient,emergency department and inpatient, along with the antibiotic use density (AUD, defined as daily doses/per 100 patient-days), the AUD of the third-generation cephalosporins and carbapenems in inpatient were reviewed retrospectively. The detection rates of extended-spectrum β-lactamases (ESBLs)-producing , ESBLs-producing , carbapenem-resistant , carbapenem-resistant , carbapenem-resistant and carbapenem-resistant were also analyzed at the same time. The correlation analysis between the detection rate of MDR-GNB and the indicator of antimicrobial usage was made. Among four stages, the usage rates were 55.2% (560 578/1 015 540) , 38.1% (493 554/1 296 336) , 26.8% (378 602/1 411 595) and 23.1% (347 817/1 502 817) in outpatient, 75.6% (429 582/568 230) , 61.4% (382 558/623 138) , 43.6% (265 102/608 071) and 35.1% (218 484/622 397) in emergency department, and 76.0% (30 568/40 221) , 53.7% (30 437/56 636) , 49.9% (37 395/74 895) and 50.3% (35 493/70 544) in inpatient, respectively. All indicators decreased significantly (χ(2)=297 811.798, 3 155 704.783, 5 592.037, 0.01). The AUD in inpatient was 38.4,31.8,21.7 and 19.41,and the AUD of the third-generation cephalosporins were 13.83, 11.21, 6.20 and 6.84, respectively, which decreased significantly after ASP (-0.878, -0.781, 0.05). The AUD of carbapenems were 1.94,1.77,1.87 and 1.93, respectively (0.123, 0.05). A total of 11 289 strains of bacteria were collected, including 5 589 strains of , 2 823 strains of , 1 637 strains of , and 1 240 strains of .The detection rates of ESBLs-producing and ESBLs -producing in four stages were 75.4% (1 034/1 371) , 66.6% (893/1 341) , 57.8% (834/1 443) , 46.7% (670/1 434) and 78.7% (547/695) , 67.5% (455/674) , 49.3% (421/854) , 32.5% (195/600) , respectively,both decreased significantly (χ(2)=266.204; 328.805, 0.01). The detection rates of Carbapenem-resistant were 28.2% (115/408) , 26.7% (126/472) , 24.3% (125/515) and 12.0% (29/242) respectively,and showed significant decreasing trend after ASP (χ(2)=18.112, 0.01). The detection rates of carbapenem-resistant were 11.3% (40/355) , 18.5% (58/313) , 13.4% (46/343) and 7.0% (16/229) , respectively,with the most obvious decrease in the third stage after ASP. The detection rates of carbapenem-resistant and carbapenem-resistant were continuously lower (<5%). There were positive correlations between the detection rates of ESBLs-producing and and all usage indicators ((1)0.930, 0.974, 0.746, 0.958, 0.842; (2)0.910, 0.960, 0.765, 0.963, 0.898, 0.05). The antimicrobial stewardship program can effectively reduce both the usage of antimicrobial and the production of MDR-GNB, which has great value to promote rational clinical use of antimicrobials and reduce bacterial resistance.

摘要

分析抗菌药物使用指标及多重耐药革兰阴性菌(MDR-GNB)检出率的变化,以评估抗菌药物管理计划(ASP)的影响。自2011年12月起,温州医科大学附属第二医院和育英儿童医院实施了抗菌药物管理计划。2014年至2017年加大了力度。我们将该计划分为四个阶段,一个是ASP实施前(2010 - 2011年),三个是ASP实施后(2012 - 2013年为第一阶段,2014 - 2015年为第二阶段,2016 - 2017年为第三阶段)。回顾性分析门诊、急诊科和住院患者的使用率,以及抗生素使用密度(AUD,定义为每日剂量/每100患者日)、住院患者中第三代头孢菌素和碳青霉烯类抗生素的AUD。同时分析产超广谱β-内酰胺酶(ESBLs)、产ESBLs、耐碳青霉烯类、耐碳青霉烯类、耐碳青霉烯类和耐碳青霉烯类的检出率。对MDR-GNB检出率与抗菌药物使用指标进行相关性分析。在四个阶段中,门诊患者使用率分别为55.2%(560578/1015540)、38.1%(493554/1296336)、26.8%(378602/1411595)和23.1%(347817/1502817),急诊科分别为75.6%(429582/568230)、61.4%(382558/623138)、43.6%(265102/608071)和35.1%(218484/622397),住院患者分别为76.0%(30568/40221)、53.7%(30437/56636)、49.9%(37395/74895)和50.3%(35493/70544)。所有指标均显著下降(χ(2)=297811.798、3155704.783、5592.037,P<0.01)。住院患者的AUD分别为38.4、31.8、21.7和19.41,第三代头孢菌素的AUD分别为13.83、11.21、6.20和6.84,ASP实施后均显著下降(P< -0.878、 -0.781,P<0.05)。碳青霉烯类抗生素的AUD分别为1.94、1.77、1.87和1.93(P>0.123,P>0.05)。共收集到11289株细菌,其中包括5589株、2823株、1637株和1240株。四个阶段中产ESBLs和产ESBLs的检出率分别为75.4%(1034/1371)、66.6%(893/1341)、57.8%(834/1443)、46.7%(670/1434)和78.7%(547/695)、67.5%(455/674)、49.3%(421/854)、32.5%(195/600),均显著下降(χ(2)=266.204;328.805,P<0.01)。耐碳青霉烯类的检出率分别为28.2%(115/408)、26.7%(126/472)、24.3%(125/515)和12.0%(29/242),ASP实施后呈显著下降趋势(χ(2)=18.112,P<0.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验